Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma

Malignant pleural mesothelioma is an aggressive tumor that has a poor prognosis and is resistant to unimodal approaches. Multimodal treatment has provided encouraging results.Phase II, open-label study of the combination of chemotherapy (pemetrexed 500 mg/m²+cisplatin 75 mg/m² IV every 21 days × 3 c...

Whakaahuatanga katoa

I tiakina i:
Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua: Rea Federico, Adolfo Favaretto, Giuseppe Marulli, Lorenzo Spaggiari, DePas Tommaso Martino, Ceribelli Anna, Adriano Paccagnella, Gino Crivellari, Russo Francesca, Matteo Ceccarelli, Kazeem Gbenga, Marchi Paolo, Francesco Facciolo
Hōputu: Artigo
Reo:Ingarihi
I whakaputaina: 2013
Urunga tuihono:https://doi.org/10.1186/1471-2407-13-22
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!